Regarding the company's research and market development in the medical industry, Jun Dingda (301538) recently stated in an institutional survey that the company focuses on the design, research, secondary processing, and assembly of precision medical catheters in this industry, providing medical catheters and other products to downstream customers. The company's wholly-owned subsidiary, Jiangmen Jun Dingda, has obtained the certification of the medical device quality management system. The subsidiary has established a 100,000-level clean workshop, and a 10,000-level clean workshop is currently under construction. In 2023, the company launched PTFE catheters, laying the foundation for the development and accumulation of customers in the medical field. The company has established connections with multiple medical device companies, some products have been supplied in large quantities, and some products are in the stages of quotation, sampling, and certification. Currently, the company's revenue from this industry is relatively small.